search
Back to results

Depot Disulfiram for AIDS and ARC

Primary Purpose

HIV Infections

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Disulfiram
Sponsored by
St. Vincent's Medical Center
About
Eligibility
Locations
Outcomes
Full info

About this trial

This is an interventional treatment trial for HIV Infections focused on measuring Delayed-Action Preparations, Disulfiram, Acquired Immunodeficiency Syndrome, AIDS-Related Complex

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria Patients must have a positive diagnosis of AIDS or AIDS related complex (ARC) according to the CDC criteria. Also patient must be: Able to understand the study. Strongly motivated to participate in the study, and willing to comply with all the conditions specified in the informed consent forms. Ambulatory and able to maintain an independent life outside the hospital. Free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status. Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status. Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status. History of alcohol abuse.

Sites / Locations

  • Saint Vincent's Med Ctr

Outcomes

Primary Outcome Measures

Secondary Outcome Measures

Full Information

First Posted
November 2, 1999
Last Updated
June 23, 2005
Sponsor
St. Vincent's Medical Center
search

1. Study Identification

Unique Protocol Identification Number
NCT00002065
Brief Title
Depot Disulfiram for AIDS and ARC
Official Title
Depot Disulfiram for AIDS and ARC
Study Type
Interventional

2. Study Status

Record Verification Date
November 1999
Overall Recruitment Status
Completed
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)

3. Sponsor/Collaborators

Name of the Sponsor
St. Vincent's Medical Center

4. Oversight

5. Study Description

Brief Summary
To assess the safety and efficacy of depot disulfiram as a new treatment for AIDS and AIDS related complex.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
HIV Infections
Keywords
Delayed-Action Preparations, Disulfiram, Acquired Immunodeficiency Syndrome, AIDS-Related Complex

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Masking
None (Open Label)

8. Arms, Groups, and Interventions

Intervention Type
Drug
Intervention Name(s)
Disulfiram

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria Patients must have a positive diagnosis of AIDS or AIDS related complex (ARC) according to the CDC criteria. Also patient must be: Able to understand the study. Strongly motivated to participate in the study, and willing to comply with all the conditions specified in the informed consent forms. Ambulatory and able to maintain an independent life outside the hospital. Free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status. Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status. Patients must be free of clinically significant organic disease affecting neurologic, hepatic, renal, and clinical status. History of alcohol abuse.
Facility Information:
Facility Name
Saint Vincent's Med Ctr
City
Staten Island
State/Province
New York
ZIP/Postal Code
10310
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Depot Disulfiram for AIDS and ARC

We'll reach out to this number within 24 hrs